Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Loss for the period $ (31,566) $ (5,303)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of intangible assets 2 8
Depreciation of property and equipment 15  
In-process research and development 16,094  
Change in fair value of milestone liability 14  
Interest expense 23  
Amortization of deferred loan costs 74  
Shares issued for services   12
Warrants issued for services 438 133
Stock option expense 4,248 307
Changes in operating assets and liabilities    
Prepaid expenses and deposits (2,596) 165
Interest, taxes and other receivables 2 16
Accounts payable and accrued liabilities (640) (659)
Related party payables (279) (29)
Net cash used in operating activities (14,171) (5,350)
Cash flows from investing activities    
Cash acquired on merger with Adgero 969  
Purchase of equipment (8)  
Proceeds on sale of equipment 3  
Net cash provided by investing activities 964  
Cash flows from financing activities    
Net proceeds from the issuance of shares and warrants 21,598 6,583
Warrants exercised for cash 4,399 27
Stock options exercised for cash 42  
Proceeds from loan 500  
Series A preferred cash dividend (6) (6)
Net cash provided by financing activities 26,533 6,604
Increase in cash and cash equivalents 13,326 1,254
Cash and cash equivalents – beginning of period 2,392 3,719
Cash and cash equivalents – end of period $ 15,718 $ 4,973